RSS

psoriasis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

The National Institute for Health and Care Excellence (NICE) has issued its final appraisal determination (FAD) to Janssen recommending Tremfya (guselkumab) for treatment of adults with moderate to severe plaque psoriasis. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Dermatology specialist, LEO Pharma, has announced that the European Commission (EC) has granted marketing authorisation for its new biologic, Kyntheum (brodalumab), for the treatment of moderate-to-severe plaque psoriasis in adults within the EU. more

News

Drug maker Leo Pharma has launched Enstilar, reportedly the first fixed-combination, cutaneous foam spray for the once-daily topical treatment of all extents of plaque psoriasis for patients who are 18 years or older in the UK more

News

Lipidor and Cadila Pharmaceuticals, one of the largest pharmaceutical manufacturing groups in India, have entered into a collaboration agreement for the commercialisation of a sprayable anti-psoriatic product more

News

Novartis has announced that important new data will be presented on secukinumab in ankylosing spondylitis at the forthcoming European League Against Rheumatism 2015 Annual Scientific Meeting, from 10–13 June, in Rome, Italy. more

News

Pharmaceutical formulation development and manufacturing services provider Molecular Profiles, a subsidiary of Columbia Laboratories, Inc., has been chosen by clinical stage biopharmaceutical company Telormedix SA to develop both topical and solid... more

Technology